This provider's $3.8M in total Medicare payments ranks in the 98th percentile of Pain Management providers nationally.
Their average markup ratio of 5.32x is significantly above the specialty median of 5.1x.
Medicare payments to this provider grew 870% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 235% in 2015
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $317.50 | $92.99 | 3.41x | $224.51 | $52.2K | 650 | 525 |
| 2015 | $430.09 | $86.50 | 4.97x | $343.59 | $174.9K | 2.0K | 1.4K |
| 2016 | $455.90 | $79.50 | 5.73x | $376.40 | $486.0K | 4.7K | 3.2K |
| 2017 | $439.24 | $74.41 | 5.90x | $364.83 | $458.1K | 5.2K | 3.2K |
| 2018 | $462.84 | $70.51 | 6.56x | $392.33 | $451.7K | 5.8K | 3.3K |
| 2019 | $517.38 | $69.19 | 7.48x | $448.19 | $448.0K | 5.6K | 3.1K |
| 2020 | $649.57 | $72.55 | 8.95x | $577.02 | $382.1K | 5.1K | 2.8K |
| 2021 | $664.44 | $82.12 | 8.09x | $582.32 | $461.6K | 5.3K | 2.5K |
| 2022 | $1.2K | $92.59 | 12.69x | $1.1K | $349.3K | 3.8K | 1.9K |
| 2023 | $1.3K | $119.53 | 10.74x | $1.2K | $505.7K | 4.2K | 2.0K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| G0482 | Drug test def 15-21 classes | 3.4K | $661.1K | $192.47 | 2.54x |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | 8.0K | $599.0K | $74.89 | 3.48x |
| 80307 | Testing for presence of drug | 7.4K | $472.7K | $64.10 | 4.31x |
| G0483 | Drug test def 22+ classes | 1.1K | $234.2K | $212.73 | 1.32x |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance | 1.1K | $196.4K | $174.38 | 7.19x |
| J7999 | Compounded drug, not otherwise classified | 199 | $176.1K | $884.78 | 17.95x |
| G0481 | Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (an | 941 | $144.0K | $153.08 | 3.41x |
| 62369 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump | 2.2K | $142.8K | $66.16 | 3.48x |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | 2.6K | $130.6K | $49.65 | 3.42x |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance | 962 | $98.2K | $102.10 | 6.31x |
| G0479 | Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, TOF, MALDI, LDTD, DESI, DART, GHPC, GC mass spectrometry), includes sample validation when | 1.0K | $78.0K | $75.98 | 1.36x |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | 2.0K | $74.1K | $37.15 | 3.37x |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | 648 | $70.7K | $109.07 | 2.83x |
| 27096 | Injection procedure into sacroiliac joint for anesthetic or steroid | 653 | $62.0K | $94.92 | 9.36x |
| 62323 | Injection of substance into spinal canal of lower back or sacrum using imaging guidance | 828 | $61.3K | $73.99 | 11.18x |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance | 387 | $60.6K | $156.67 | 8.35x |
| 64494 | Injections of lower or sacral spine facet joint using imaging guidance | 957 | $56.3K | $58.86 | 8.58x |
| 64490 | Injections of upper or middle spine facet joint using imaging guidance | 419 | $46.6K | $111.21 | 7.81x |
| 64636 | Destruction of lower or sacral spinal facet joint nerves with imaging guidance | 907 | $45.3K | $49.89 | 23.27x |
| 64495 | Injections of lower or sacral spine facet joint using imaging guidance | 741 | $45.0K | $60.72 | 8.37x |
This provider submits charges 5.32 times higher than what Medicare actually pays.
A markup ratio of 5.32x means for every $100 Medicare pays, this provider initially charges $532. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data